612 related articles for article (PubMed ID: 23018431)
1. In right or biventricular chronic heart failure addition of thiazides to loop diuretics to achieve a sequential blockade of the nephron is associated with increased risk of dilutional hyponatremia: results of a case-control study.
De Vecchis R; Ariano C; Esposito C; Giasi A; Cioppa C; Cantatrione S
Minerva Cardioangiol; 2012 Oct; 60(5):517-29. PubMed ID: 23018431
[TBL] [Abstract][Full Text] [Related]
2. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
[TBL] [Abstract][Full Text] [Related]
3. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
[TBL] [Abstract][Full Text] [Related]
4. Unloading therapy by intravenous diuretic in chronic heart failure: a double-edged weapon?
De Vecchis R; Ciccarelli A; Pucciarelli A
J Cardiovasc Med (Hagerstown); 2010 Aug; 11(8):571-4. PubMed ID: 20588135
[TBL] [Abstract][Full Text] [Related]
5. [Value of aldosterone receptor blockade in diuretic therapy of patients with chronic heart failure].
Christ M; Ludwig N; Maisch B
Herz; 2002 Mar; 27(2):135-49. PubMed ID: 12025459
[TBL] [Abstract][Full Text] [Related]
6. Comparison of metolazone versus chlorothiazide in acute decompensated heart failure with diuretic resistance.
Moranville MP; Choi S; Hogg J; Anderson AS; Rich JD
Cardiovasc Ther; 2015 Apr; 33(2):42-9. PubMed ID: 25712736
[TBL] [Abstract][Full Text] [Related]
7. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure.
Paterna S; Di Pasquale P; Parrinello G; Amato P; Cardinale A; Follone G; Giubilato A; Licata G
Eur J Heart Fail; 2000 Sep; 2(3):305-13. PubMed ID: 10938493
[TBL] [Abstract][Full Text] [Related]
8. Renal effects of conivaptan, furosemide, and the combination in patients with chronic heart failure.
Goldsmith SR; Gilbertson DT; Mackedanz SA; Swan SK
J Card Fail; 2011 Dec; 17(12):982-9. PubMed ID: 22123359
[TBL] [Abstract][Full Text] [Related]
9. Plasma copeptin levels and prediction of outcome in heart failure outpatients: relation to hyponatremia and loop diuretic doses.
Balling L; Kistorp C; Schou M; Egstrup M; Gustafsson I; Goetze JP; Hildebrandt P; Gustafsson F
J Card Fail; 2012 May; 18(5):351-8. PubMed ID: 22555263
[TBL] [Abstract][Full Text] [Related]
10. Combination of loop diuretics with thiazide-type diuretics in heart failure.
Jentzer JC; DeWald TA; Hernandez AF
J Am Coll Cardiol; 2010 Nov; 56(19):1527-34. PubMed ID: 21029871
[TBL] [Abstract][Full Text] [Related]
11. Effects of Tolvaptan Addition to Furosemide in Normo- and Hyponatremia Patients with Heart Failure and Chronic Kidney Disease Stages G3b-5: A Subanalysis of the K-STAR Study.
Tominaga N; Kida K; Inomata T; Sato N; Izumi T; Akashi YJ; Shibagaki Y
Am J Nephrol; 2017; 46(5):417-426. PubMed ID: 29130954
[TBL] [Abstract][Full Text] [Related]
12. Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure.
Veeraveedu PT; Watanabe K; Ma M; Palaniyandi SS; Yamaguchi K; Kodama M; Aizawa Y
Biochem Pharmacol; 2008 Mar; 75(6):1322-30. PubMed ID: 18179782
[TBL] [Abstract][Full Text] [Related]
13. [Diuretic therapy in acute heart failure].
Trullàs JC; Morales-Rull JL; Formiga F
Med Clin (Barc); 2014 Mar; 142 Suppl 1():36-41. PubMed ID: 24930082
[TBL] [Abstract][Full Text] [Related]
14. Current treatments and novel pharmacologic treatments for hyponatremia in congestive heart failure.
Goldsmith SR
Am J Cardiol; 2005 May; 95(9A):14B-23B. PubMed ID: 15847853
[TBL] [Abstract][Full Text] [Related]
15. Predisposing factors for acute kidney injury in Hispanic patients treated with diuretics for decompensated heart failure.
Ricci F; Ramírez T; Marmorato R; Vega J; Pagán P; López JE; Soto-Salgado M; Cangiano JL
P R Health Sci J; 2013 Jun; 32(2):63-7. PubMed ID: 23781621
[TBL] [Abstract][Full Text] [Related]
16. Hyponatremia in congestive heart failure.
Oren RM
Am J Cardiol; 2005 May; 95(9A):2B-7B. PubMed ID: 15847851
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive review of the loop diuretics: should furosemide be first line?
Wargo KA; Banta WM
Ann Pharmacother; 2009 Nov; 43(11):1836-47. PubMed ID: 19843838
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of combination diuretic therapy with oral hydrochlorothiazide or intravenous chlorothiazide in patients receiving intravenous furosemide therapy for the treatment of heart failure.
Kissling KT; Pickworth KK
Pharmacotherapy; 2014 Aug; 34(8):882-7. PubMed ID: 24990816
[TBL] [Abstract][Full Text] [Related]
19. Treating hyponatremia in heart failure.
Goldsmith SR
Curr Cardiol Rep; 2006 May; 8(3):204-10. PubMed ID: 17552085
[TBL] [Abstract][Full Text] [Related]
20. Hyponatremia in acute decompensated heart failure: depletion versus dilution.
Verbrugge FH; Steels P; Grieten L; Nijst P; Tang WH; Mullens W
J Am Coll Cardiol; 2015 Feb; 65(5):480-92. PubMed ID: 25660927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]